107 related articles for article (PubMed ID: 3112993)
1. Tissue-type plasminogen activator and streptokinase induce platelet hyperaggregability in the rabbit.
Ohlstein EH; Storer B; Fujita T; Shebuski RJ
Thromb Res; 1987 May; 46(4):575-85. PubMed ID: 3112993
[TBL] [Abstract][Full Text] [Related]
2. Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits.
Montrucchio G; Alloatti G; Mariano F; Lupia E; Lucchina PG; Musso E; Emanuelli G; Camussi G
Circ Res; 1993 Mar; 72(3):658-70. PubMed ID: 8381725
[TBL] [Abstract][Full Text] [Related]
3. Effects of streptokinase, urokinase, and recombinant tissue plasminogen activator on platelet aggregability and stability of platelet aggregates.
Terres W; Umnus S; Mathey DG; Bleifeld W
Cardiovasc Res; 1990 Jun; 24(6):471-7. PubMed ID: 2167173
[TBL] [Abstract][Full Text] [Related]
4. Temporal effects of thrombolytic agents on platelet function in vivo and their modulation by prostaglandins.
Rudd MA; George D; Amarante P; Vaughan DE; Loscalzo J
Circ Res; 1990 Nov; 67(5):1175-81. PubMed ID: 2146037
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of low-dose tissue plasminogen activator and streptokinase on platelet aggregation.
Berridge DC; Burgess-Wilson ME; Westby JC; Hopkinson BR; Makin GS
Br J Surg; 1989 Oct; 76(10):1026-30. PubMed ID: 2513082
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of streptokinase, t-PA and APSAC on human platelet aggregation in vitro in the absence and presence of aspirin.
Fears R; Ferres H; Greenwood HC
Thromb Res; 1990 Nov; 60(4):259-68. PubMed ID: 2128420
[TBL] [Abstract][Full Text] [Related]
7. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
Parise P; Hauert J; Iorio A; Callegari P; Agnelli G
J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212
[TBL] [Abstract][Full Text] [Related]
8. Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
Lynch JJ; Cook JJ; Sitko GR; Holahan MA; Ramjit DR; Mellott MJ; Stranieri MT; Stabilito II; Zhang G; Lynch RJ
J Pharmacol Exp Ther; 1995 Jan; 272(1):20-32. PubMed ID: 7815334
[TBL] [Abstract][Full Text] [Related]
9. Platelet activation and subsequent inhibition by plasmin and recombinant tissue-type plasminogen activator.
Penny WF; Ware JA
Blood; 1992 Jan; 79(1):91-8. PubMed ID: 1530814
[TBL] [Abstract][Full Text] [Related]
10. Platelet function after in vivo and in vitro treatment with thrombolytic agents.
Bertolino G; Noris P; Previtali M; Gamba G; Ferrario M; Montani N; Balduini CL
Am J Cardiol; 1992 Feb; 69(5):457-61. PubMed ID: 1736606
[TBL] [Abstract][Full Text] [Related]
11. Platelet aggregation measured in rabbit whole blood: in vitro study of 3 aggregating agents and ex vivo inhibition by aspirin and ticlopidine.
Chevolet C; Grosdent JC; Reiters GM; Dresse A
Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):310-1. PubMed ID: 6817725
[No Abstract] [Full Text] [Related]
12. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism.
Mühl D; Füredi R; Gecse K; Ghosh S; Falusi B; Bogár L; Roth E; Lantos J
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):661-7. PubMed ID: 17890954
[TBL] [Abstract][Full Text] [Related]
13. [Changes in oxidative stress and hemostatic parameters in the course of thrombolytic therapy of pulmonary embolism].
Mühl D
Orv Hetil; 2008 May; 149(20):935-48. PubMed ID: 18467263
[TBL] [Abstract][Full Text] [Related]
14. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
[TBL] [Abstract][Full Text] [Related]
15. In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis.
Gouin I; Lecompte T; Morel MC; Lebrazi J; Modderman PW; Kaplan C; Samama MM
Circulation; 1992 Mar; 85(3):935-41. PubMed ID: 1531623
[TBL] [Abstract][Full Text] [Related]
16. A novel platelet-rich arterial thrombosis model in rabbits. Simple, reproducible, and dynamic real-time measurement by using double-opposing inverted-sutures model.
Shieh SJ; Chiu HY; Shi GY; Wu CM; Wang JC; Chen CH; Wu HL
Thromb Res; 2001 Sep; 103(5):363-76. PubMed ID: 11553369
[TBL] [Abstract][Full Text] [Related]
17. Effects of methylprednisolone and hydrocortisone on aggregation of rabbit platelets induced by arachidonic acid and other aggregating substances.
Glass F; Lippton H; Kadowitz PJ
Thromb Haemost; 1981 Dec; 46(4):676-9. PubMed ID: 6800048
[TBL] [Abstract][Full Text] [Related]
18. Aggregation of washed platelets by plasminogen and plasminogen activators is mediated by plasmin and is inhibited by a synthetic peptide disulfide.
Puri RN; Hu CJ; Matsueda R; Umeyama H; Colman RW
Thromb Res; 1992 Mar; 65(4-5):533-47. PubMed ID: 1535463
[TBL] [Abstract][Full Text] [Related]
19. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
[TBL] [Abstract][Full Text] [Related]
20. Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells.
Montrucchio G; Bergerone S; Bussolino F; Alloatti G; Silvestro L; Lupia E; Cravetto A; Di Leo M; Emanuelli G; Camussi G
Circulation; 1993 Oct; 88(4 Pt 1):1476-83. PubMed ID: 8403295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
